Skip to navigationSkip to contentSkip to footer
Need Help?770-729-2992
MY ACCOUNT
CART
RayBiotech
RayBiotech
  • Products
    • Multiplex Assays
    • ELISA Kits
    • Proteins
    • Antibodies
    • Flow Cytometry
    • Assay Kits
    • Molecular Biology
    • Other Products
    • Human Cytokine Array C5
    • Human IL-6 ELISA
    • Human Inflammation Array Q3
    • Mouse Cytokine Array C3
    • Recombinant SARS-CoV-2 Spike Protein, S1 Subunit
    • Human Phosphorylation Pathway Profiling Array C55
    • Antibody Arrays
    • Proteome Profiling Arrays
    • Cytometric Bead Arrays
    • Epitope Mapping Peptide Arrays
    • Protein Arrays
    • PTM Multiplex Assays
    • NexaTag® Ultrasensitive Multiplex ELISA
    • Sandwich ELISA
    • Competitive ELISA
    • PTM ELISA
    • NexaTag® Ultrasensitive qIPCR ELISA
    • Indirect ELISA
    • Bridging ELISA
    • Cell-Based ELISA
    • Recombinant Proteins
    • GMP Proteins
    • Native Proteins
    • Peptides
    • Primary Antibodies
    • Secondary Antibodies
    • Flow Cytometry Antibodies
    • Isotype Controls
    • Antibody Pairs
    • Flow Cytometry Antibodies
    • Flow Cytometry Reagents
    • Flow Cytometry Assays
    • Cytometric Bead Arrays
    • Fluorescent Beads
    • Quantum Dots
    • Metabolism Assays
    • Ligand Binding Assays
    • Drug Antibody (DA) & ADA Assays
    • Transcription Factor Activity Assays
    • PCR Assays
    • Nucleic Acid Assays
    • Epigenetics
    • Mitochondrial Assays
    • Reagents
    • Cell Culture
    • Biospecimen Samples
    • Sample Collection & Preparation
    • Lysates
    • Magnetic Beads
    • Lab Equipment and Supplies
    • Biological Buffers

    Featured Products

    Human Cytokine Array C5Human IL-6 ELISAHuman Inflammation Array Q3Mouse Cytokine Array C3Recombinant SARS-CoV-2 Spike Protein, S1 SubunitHuman Phosphorylation Pathway Profiling Array C55
  • Services
    • Multiplex Assay Services
    • ELISA Services
    • Protein Services
    • Antibody Services
    • CRO Services
    • Flow Cytometry Services
    • SIMOA – Single Molecule Array
    • Other Services
    • Quantitative Proteomics Services
    • Discovery Proteomics Services
    • Custom Arrays
    • Array Scanning and Analysis
    • Custom Protein Production
    • GMP Protein Production
    • IHC Controls
    • Stable Cell Line Development
    • Molecular Biology Services
    • Antibody Production
    • Recombinant Antibody Expression
    • Bulk Antibody Production
    • Antibody Conjugation Services
    • Cell Biology Services
    • Epitope Mapping Services
    • Biomarker Discovery
    • Cell Biology Services
    • Antibody Drug Development & Characterization
    • Pharmacokinetic and Pharmacodynamic Analysis
    • Assay Development Services
    • Molecular Biology Services
    • Multiomics Services
    • Diagnostic Assay Development
    • GMP Protein Production
    • Biostatistics and Bioinformatics
    • Bulk Antibody Production
    • QC Testing Services
    • Auto-Western Blot Service
    • COVID-19 Pseudovirus Service
    • Biospecimen Samples & Sample Services
    • RNA & DNA Methylation Detection Services
  • Research Areas
    • Cell Signaling Pathways
    • Areas of Interest
    • Akt Signaling Pathway
    • AMPK Signaling pathway
    • ErbB Signaling Pathway
    • Hedgehog Signaling Pathway
    • HIF1-alpha Signaling Pathway
    • IGFR1 Signaling Pathway
    • JAK-STAT Signaling Pathway
    • MAPK Signaling Pathway
    • mTOR Signaling Pathway
    • NF-kappaB Signaling Pathway
    • Notch Signaling Pathway
    • p53 Signaling Pathway
    • PKC Pathway
    • TGF-beta Signaling Pathway
    • Wnt/beta-Catenin Pathway
    • Antibody Drug Development
    • Autoimmunity & Inflammation
    • Cancer
    • Cardiovascular Disease
    • Infectious Disease & Vaccines
    • Neuroscience
    • Obesity
    • Post Translational Modifications
    • RNA & DNA Modifications
  • Resources
    • Array Picker Tool
    • Sample Shipment Instructions
    • Sample Preparation Tips
    • Publications / Citations
    • Promotions
    • Resource Library
    • Learning Center
    • Manual Protocols
    • Array Analysis Tools
  • Contact Us
    • Distributors & Service Providers
  • About Us
    • Quality Systems
    • Business Partnerships
    • Careers
    • News & Events
Products
  • Multiplex Assays
  • ELISA Kits
  • Proteins and Peptides
  • Antibodies
  • Flow Cytometry
  • Assay Kits
  • Molecular Biology

Sign up to get promotions on your favorite research tools and research updates.

Sign up to Newsletter (opens in new tab)
Services
  • Multiplex Assay Services
  • ELISA Services
  • Antibody Services
  • Custom Protein Services
  • CRO Services
  • Flow Cytometry Services
  • Simoa – Single Molecule Array Services
Resources
  • Manual Protocols
  • Resource Library
  • Learning Center
  • Array Analysis Tools
  • Publications / Citations
  • Publications by RayBiotech Scientists
About Us
  • About RayBiotech
  • Careers
  • Quality Systems
  • Business Partnerships
  • News & Events
  • Reducing Our Emissions
Contact Us
  • Contacts
  • Distributors
  • Certified Service Providers
ISO 13485:2016cGMP
ISO 17025:2017CLIA
©2007-2026 RayBiotech, Inc. All rights reserved.Life Science Web Design By Supreme
  • Privacy Policy
  • Terms & Conditions
  • ISO Certification
  • Risk Free Guarantee
  • Promotions

Your cart is empty.

  • Home
  • Learning Center
  • Biostatistics & Bioinformatics
  • SAM (Significance Analysis of Microarray)
November 21, 2018|Biostatistics & Bioinformatics|Valerie Jones, PhD

SAM (Significance Analysis of Microarray)

What is it? SAM is a method used for large-scale gene or protein expression data like those collected with microarrays. It addresses the issue of analyzing large-scale data in which a microarray experiment of 10,000 proteins would identify 100 proteins by chance using a p-value cut-off of 0.01. Therefore, SAM applies a t-test at the individual gene or protein level to determine whether the expression pattern for that gene or protein is significant.

When is it used? This test is performed when the samples 1) may not be independent of each other and 2) are or are not normally distributed. It can help identify expression patterns that have little difference between the control and test groups but are nevertheless significant.

How does it work?

SAM Example

We want to find serological proteins that are different between 12 healthy and 12 diseased patients using an antibody-based microarray targeting 1,000 proteins.

  1. The observed relative difference per protein across groups is determined, which considers the mean and variance of each group (Figure 1). This step accounts for protein-specific fluctuations.
  2. The expected relative difference per protein across groups is determined by averaging the protein responses across numerous permutations. An example of a permutation is given in Figure 2 in which a group label (e.g., healthy, diseased) is assigned at random. These random permutations form a simulated distribution of expected relative differences (like a t-statistic). The random permutations are also used to calculate the false discovery (FDR), or the rate at which a protein will be incorrectly identified as significant.
  3. Plot the observed vs expected relative difference (Figure 3). This is a visual way of looking at the data.

Leave a Reply

  • Identify proteins-of-interest that deviate from the diagonal line using a threshold (dashed lines in Figure 3). The threshold is determined by calculating false discovery rates (FDRs) using data from the permutations.
  • Determine the statistical significance of the proteins-of-interest. Biomarkers with larger deviations between the observed (step 1) and expected (step 2) relative difference are deemed significant. In other words, the larger the deviation and lower the FDR, the higher the significance.
  • SAM Figure 1 — Protein 1 expression histograms

    Figure 1. Histogram plots of Protein 1 expression in different populations.

    SAM Figure 2 — Permutation example for Protein 1

    Figure 2. Permutation example for Protein 1. Note than an equal number of datasets from healthy (blue) and diseased (green) patients are being compared to each other. The "healthy" and "diseased" data sets would be compared in this permutation. Numerous permutations would be performed.

    SAM Figure 3 — Observed vs expected scatter plot

    Figure 3. Scatter plot of observed vs. expected relative differences (t-statistic) of a protein. Dashed lines = threshold cut-off. Figure altered from Tusher et al. Proc Natl Acad Sci. 2001 Apr 24; 98(9): 5116-5121.

    What does the data look like? For each gene or protein, SAM produces a test statistic value based upon the observed value’s deviation from the expected value. Unlike other models that use a p-value or FDR, SAM determines significance based on the deviation of the observed data from the expected value; the expected value is based on numerous permutations of the original data.